Column Group Opportunity Iii, Lp - Net Worth and Insider Trading
Column Group Opportunity Iii, Lp Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Column Group Opportunity Iii, Lp owns 2 companies in total, including NGM Biopharmaceuticals Inc (NGM) , and Tenaya Therapeutics Inc (TNYA) .
Insider Ownership Summary of Column Group Opportunity Iii, Lp
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| NGM | NGM Biopharmaceuticals Inc | 2022-10-25 | 10 percent owner |
| TNYA | Tenaya Therapeutics Inc | 2022-11-21 | 10 percent owner |
Column Group Opportunity Iii, Lp Trading Performance
Column Group Opportunity Iii, Lp Ownership Network
Ownership Network List of Column Group Opportunity Iii, Lp
Ownership Network Relation of Column Group Opportunity Iii, Lp
Column Group Opportunity Iii, Lp Owned Company Details
What does NGM Biopharmaceuticals Inc do?
Who are the key executives at NGM Biopharmaceuticals Inc?
Column Group Opportunity Iii, Lp is the 10 percent owner of NGM Biopharmaceuticals Inc. Other key executives at NGM Biopharmaceuticals Inc include director & 10 percent owner David V Goeddel , 10 percent owner Column Group L P , and Chief Financial Officer Jean-frederic Viret .
NGM Biopharmaceuticals Inc (NGM) Insider Trades Summary
Over the past 18 months, Column Group Opportunity Iii, Lp made no insider transaction in NGM Biopharmaceuticals Inc (NGM). Other recent insider transactions involving NGM Biopharmaceuticals Inc (NGM) include a net purchase of 67,893 shares made by Column Group L P , and a net purchase of 26,811 shares made by David V Goeddel .
In summary, during the past 3 months, insiders sold 0 shares of NGM Biopharmaceuticals Inc (NGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of NGM Biopharmaceuticals Inc (NGM) were sold and 94,704 shares were bought by its insiders, resulting in a net purchase of 94,704 shares.
NGM Biopharmaceuticals Inc (NGM)'s detailed insider trading history can be found in Insider Trading Tracker table.
NGM Biopharmaceuticals Inc Insider Transactions
Column Group Opportunity Iii, Lp Mailing Address
Above is the net worth, insider trading, and ownership report for Column Group Opportunity Iii, Lp. You might contact Column Group Opportunity Iii, Lp via mailing address: 1 Letterman Drive, Building D, Suite Dm-900, San Francisco Ca 94129.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
